A functional medicine approach to diabetes control and quality of life: an open-label randomized pilot study

Area of Science:

• Endocrinology
• Metabolic Diseases
• Integrative Medicine

Background:

• Growing public interest in functional medicine (FM) for type 2 diabetes (T2D) care.
• Uncertainty regarding FM's efficacy beyond conventional diabetes management.
• This study investigated FM as an adjunct to usual care (UC) for T2D.

Purpose of the Study:

• To compare the effectiveness of functional medicine (FM) plus usual care (UC) against UC alone in managing type 2 diabetes (T2D).
• To assess if FM can improve glycemic control, reduce insulin dependence, and enhance metabolic biomarkers in T2D patients.

Main Methods:

• A 24-month unblinded randomized trial involving T2D participants.
• Randomization into either FM (intensive lifestyle modifications, supplements) or UC groups.
• Primary endpoint: insulin discontinuation or HbA1c < 7% at 12 months; secondary endpoints: HbA1c changes, insulin dosage, biomarkers, hypoglycemia, medications, quality of life.

Main Results:

• 34 participants randomized to FM, 37 to UC; 47 completed the study.
• Primary endpoint achievement: 15.8% in FM vs. 11.1% in UC (p=0.68), not statistically significant.
• No significant differences observed in secondary endpoints, including HbA1c, insulin dosage, cardiometabolic biomarkers, or quality-of-life scores between groups.

Conclusions:

• The addition of functional medicine (FM) to usual care (UC) did not yield statistically significant improvements for type 2 diabetes (T2D) patients.
• No added benefits were found in glycemic control, metabolic health, or quality of life compared to conventional endocrinology management alone.
• Further research may be needed to identify specific patient subgroups or intervention components within FM that could offer benefits for T2D management.